Detalles de la búsqueda
1.
Selective RET kinase inhibition for patients with RET-altered cancers.
Ann Oncol
; 29(8): 1869-1876, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29912274
2.
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy.
Ann Oncol
; 24(9): 2256-61, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23676418
3.
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.
J Clin Endocrinol Metab
; 91(3): 926-32, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16384850
4.
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors.
Arch Dermatol Res
; 308(5): 357-65, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27098388
5.
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
J Clin Endocrinol Metab
; 94(4): 1310-6, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19158200
6.
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal.
J Clin Endocrinol Metab
; 94(11): 4171-9, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19850694
Resultados
1 -
6
de 6
1
Próxima >
>>